GlaxoSmithKline PLC (NYSE:GSK)
Tuesday’s Trading Day
| 52.65 |  +0.44 / +0.84% |
Data as of May 21 | Day’s Change |
Wednesday’s Pre-Market Switch to standard view »
| 52.81 | +0.16 / +0.30% |
Volume: 4.8K |
Latest GSK News | Press Releases
| XenoPort Candidate Disappoints - Analyst Blog May 21 / Zacks.com | Elan in Royalty Deal with THRX - Analyst Blog May 14 / Zacks.com |
| Elan Provides Strategic Update - Analyst Blog May 21 / Zacks.com | Wider-than-Expected Loss at ChemoCentryx - Analyst Blog May 14 / Zacks.com |
| GlaxoSmithKline Stock Hits New 52-Week High (GSK) May 21 / TheStreet.com | Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog May 13 / Zacks.com |
| Aveo Screwed Up but Its Kidney Cancer Drug Is Real May 15 / TheStreet.com | Isis Reports In-Line Loss - Analyst Blog May 08 / Zacks.com |
| Dirty Medicine May 15 / Fortune | European drug stocks are on a tear Apr 24 / CNNMoney.com |
Today’s Trading
| Previous close | 52.21 |
| Today’s open | 52.01 |
| Day’s range | -- - -- |
| Volume | 2,399,742 |
| Average volume (3 months) | 2,753,432 |
| Market cap | $129.7B |
| Dividend yield | 4.46% |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -12.13% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +8.13% |
| Revenue growth (last year) | -4.52% |
| P/E ratio | -- |
| Price/Sales | 2.54 |
| Price/Book | 13.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck & Co Inc | +2.12 | +4.69% |
| SNYSanofi SA | +1.21 | +2.25% |
| NVSNovartis AG | +0.47 | +0.63% |
| NVONovo Nordisk A/S | -0.54 | -0.31% |
Data as of 4:03pm ET, 05/21/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.84 |
| Annual revenue (last year) | $42.1B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 17.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Andrew Philip Witty |
Chief Financial Officer & Executive Director Simon Dingemans |
Corporate headquarters Brentford, Greater London |
Forecasts
